Active-ingredient Dossier
Salbutamol Sulfate
Active-ingredient Dossier for Salbutamol Sulfate (short acting beta agonist). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: ASMOL
- Brand: SALBUTAMOL
- Brand: ZEMPREON
- Brand: Salbutamol/Bromhexine
- Therapeutic area: Respiratory
What is
Salbutamol Sulfate Salbutamol Sulfate is a short acting beta agonist.
Australian brands containing
Salbutamol Sulfate — AIROMIR — VENTOLIN — ASMOL — SALBUTAMOL — ZEMPREON
Therapeutic areas
Salbutamol Sulfate is registered in the respiratory therapeutic area, with 8 brands containing this ingredient on the ARTG.
Sponsor landscape
The ingredient is marketed by four sponsors: Cipla, iNova Pharmaceuticals, Alphapharm, and GlaxoSmithKline.
PBS and regulatory activity
Two brands containing Salbutamol Sulfate have PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome on record is from 1 March 2020, and no AusPARs have been recorded for this ingredient.